Madrigal Pharmaceuticals initiated at B. Riley FBR
Madrigal Pharmaceuticals initiated with a Neutral at B. Riley FBR. B. Riley FBR analyst Mayank Mamtani started Madrigal Pharmaceuticals with a Neutral rating and $124 price target.https://thefly.com/landingPageNews.php?id=2835691
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.